Deepak Ajmani - Feb 16, 2023 Form 3 Insider Report for Wendy's Co (WEN)

Role
Chief Operations Officer - U.S
Signature
/s/ Deepak Ajmani
Stock symbol
WEN
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
3
Date filed
2/27/2023, 04:03 PM
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WEN Common Stock 637 Feb 16, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 27.3K $8.22 Direct F1, F2
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 31.7K $9.86 Direct F1, F3
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 27.2K $10.09 Direct F1, F4
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 20K $15.36 Direct F1, F5
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 15.2K $18.52 Direct F1, F6
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 25.7K $19.71 Direct F1, F7
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 14.6K $22.34 Direct F1, F8
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 11.1K $23.70 Direct F1, F9
holding WEN Employee Stock Option (Right to Buy) Feb 16, 2023 Common Stock 14.2K $21.40 Direct F1, F10
holding WEN Restricted Stock Units Feb 16, 2023 Common Stock 3.79K $0.00 Direct F11, F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 With tandem net exercise and tax withholding rights.
F2 The option vested in three equal installments on August 11, 2015, 2016 and 2017 and is currently exercisable as to all 27,277 shares.
F3 The option vested in three equal installments on August 7, 2016, 2017 and 2018 and is currently exercisable as to all 31,656 shares.
F4 The option vested in three equal installments on August 12, 2017, 2018 and 2019 and is currently exercisable as to all 27,166 shares.
F5 The option vested in three equal installments on August 11, 2018, 2019 and 2020 and is currently exercisable as to all 20,003 shares.
F6 The option vested in three equal installments on August 20, 2019, 2020 and 2021 and is currently exercisable as to all 15,152 shares.
F7 The option vested in three equal installments on August 9, 2020, 2021 and 2022 and is currently exercisable as to all 25,707 shares.
F8 The option became exercisable as to 4,874 shares on each of August 7, 2021 and 2022 and becomes exercisable as to 4,875 shares on August 7, 2023.
F9 The option became exercisable as to 3,685 shares on August 12, 2022 and becomes exercisable as to 3,685 shares on each of August 12, 2023 and 2024.
F10 The option becomes exercisable as to 4,740 shares on each of August 13, 2023 and 2024 and becomes exercisable as to 4,741 shares on August 13, 2025.
F11 With tandem dividend equivalent rights and tax withholding rights.
F12 The restricted stock units (161 of which represent dividend equivalent units) will vest on February 19, 2024, subject to Mr. Ajmani's continued employment with the Company on the vesting date.
F13 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

Remarks:

Power of attorney is included with this filing as Exhibit 24.